![Joseph Jimenez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Jimenez
Direktor/Vorstandsmitglied bei
GENERAL MOTORS COMPANY
Vermögen: 9 Mio $ am Heute
Profil
Herr Joseph Jimenez ist ein unabhängiger Direktor bei Graphite Bio, ein Vorsitzender bei Century Therapeutics LLC, ein Direktor & Geschäftsführer bei Aditum Bio Fund 1 LP, ein unabhängiger Direktor bei Procter & Gamble Co. und ein unabhängiger Direktor bei General Motors Co. sowie ein Präsident bei European Federation of Pharmaceutical Industries & Assns. Er ist Mitglied des Board of Directors bei Graphite Bio, Aditum Bio Fund 1 LP, Procter & Gamble Co. und General Motors Co. Herr Jimenez war zuvor als Chairman-Elect bei Pharmaceutical Research & Manufacturers of America, als unabhängiges Verwaltungsratsmitglied bei Colgate-Palmolive Co., als Verwaltungsratsvorsitzender bei Speedel Holding AG, als Generaldirektor bei Novartis Pharma Schweiz AG, als Chief Executive Officer bei Novartis AG, als Chief Executive Officer bei Novartis Consumer Health, Inc, ein nicht-exekutives Mitglied des Verwaltungsrats bei AstraZeneca Plc, ein Executive Vice President bei H.J. Heinz Co., ein President, Chief Executive Officer & Executive VP bei Heinz Europe Ltd. ein President & Chief Executive Officer bei Heinz North America Consumer Products, ein President & Senior Vice President bei ConAgra Foods, Inc. ein Chief Executive Officer bei Novartis Pharmaceuticals Corp. und ein Chairman bei Speedel Pharma AG. Außerdem war er Vorstandsmitglied bei uBiome, Inc. und Blue Nile, Inc. sowie bei Pinnacle Foods Finance LLC und Pinnacle Foods Group LLC. Er erhielt seinen Bachelor-Abschluss von der Stanford University und einen MBA von der University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 37.016 ( 0 % ) | 5 Mio $ | 31.05.2026 | |
| 06.04.2026 | 32.330 ( 0 % ) | 3 Mio $ | 31.05.2026 | |
| 12.06.2025 | 494.345 ( 0,27 % ) | 1 Mio $ | 31.05.2026 | |
-.--% | 05.06.2026 | 72.498 ( -.--% ) | - $ | Heute |
Aktuelle Nachrichten zu Joseph Jimenez
Aktive Positionen von Joseph Jimenez
| Unternehmen | Position | Beginn |
|---|---|---|
| GENERAL MOTORS COMPANY | Direktor/Vorstandsmitglied | 09.06.2015 |
| PROCTER & GAMBLE COMPANY | Direktor/Vorstandsmitglied | 01.03.2018 |
Teres Bio, Inc.
 Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Direktor/Vorstandsmitglied | - |
Anteris Bio, Inc.
 Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Direktor/Vorstandsmitglied | - |
Via Nova Therapeutics, Inc.
 Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Direktor/Vorstandsmitglied | - |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Aditum Bio Management Co. LLC
 Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is an active manager. | Gründer | - |
Aditum Bio Fund 1 LP
 Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Direktor/Vorstandsmitglied | 01.07.2019 |
Ehemalige bekannte Positionen von Joseph Jimenez
| Unternehmen | Position | Ende |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Vorsitzender | 14.08.2025 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Joseph Jimenez
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
31
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 31 |
|---|---|
Colgate-Palmolive Co.
 Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Conagra Brands, Inc.
 Conagra Brands, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food company that engages in food making business | Consumer Non-Durables |
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Blue Nile, Inc.
 Blue Nile, Inc. Specialty StoresRetail Trade Retails diamonds and jewelry through online | Retail Trade |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Pinnacle Foods Group LLC
 Pinnacle Foods Group LLC Food: Specialty/CandyConsumer Non-Durables Manufactures, markets and distributes frozen food products | Consumer Non-Durables |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Heinz North America Consumer Products
 Heinz North America Consumer Products Food: Specialty/CandyConsumer Non-Durables Manufactures snack foods | Consumer Non-Durables |
Speedel Holding AG
 Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Health Technology |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Pinnacle Foods Finance LLC
 Pinnacle Foods Finance LLC Food: Major DiversifiedConsumer Non-Durables Manufactures and distributes convenience food products | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Novartis Consumer Health, Inc.
 Novartis Consumer Health, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
General Motors Co.
 General Motors Co. Motor VehiclesConsumer Durables Develops, manufactures and markets cars, trucks and automobile parts | Consumer Durables |
Heinz Europe Ltd. | |
The Blackstone Group
 The Blackstone Group Investment ManagersFinance Provides investment advisory services | Finance |
uBiome, Inc.
 uBiome, Inc. BiotechnologyHealth Technology Operates as a microbiome company | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Aditum Bio Fund 1 LP
Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Aditum Bio Management Co. LLC
Aditum Bio Management Co. LLC Investment ManagersFinance Aditum Bio Management Co. LLC is an active manager. | Finance |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for acute and sub acute viral infections | Health Technology |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Health Technology |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Health Technology |
